The goal is to investigate brain systems that mediate cognitive, affective, and rewardprocessing in humans and to determine how these systems are influenced by late life depression, bygenetic risk factors associated with depression, and by experimental manipulations of serotoninlevels. Behavioral challenge tasks will be use during functional magnetic resonance imaging (fMRI) toinvestigate four specific aims: (1) We will complete studies initiated in the current funding period thatinvestigate the influence of vascular lesions upon the interaction of ventral systems for emotionalregulation and dorsal systems for executive control in patients with late life depression. Theseon-going studies also include an assessment of current clinical status, and whether treatment hasled to a remission from depression. (2) We will characterize genetic influences upon the neuralprocessing of emotional and rewarding stimuli using a task developed in current period thatmeasures activity in amygdala, ventromedial and orbital frontal cortex, and ventral frontal cortex, and asecond task that measures activity in striatal, midbrain, and dorsal systems associated withdecisions about rewards. (3) We will evaluate the effects of neurotransmitter levels upon the neuralprocessing of emotional and rewarding stimuli. Neuroimaging and neurophysiological studiesreveal correlations between measures of neuronal activity and measures of behavioral states (e.g.,mood, decision preference, response time). Such correlations suggest functional relationships, buttypically remain untested. To functionally probe the effects of emotional/reward systems uponexecutive processing systems, we will pharmacologically manipulate levels of the neurotransmitterserotonin using ATD. Observation of systematic shifts in mood, behavioral preferences, or sensitivityto reward outcomes would have profound implications for understanding phenotypic variation inbehavior associated with conditions such as depression, addiction, and anxiety syndromes. (4) Wewill evaluate the effects of mood changes upon the neural processing of emotional and rewardingstimuli. A common consequence of depression is anhedonia, or the inability to derive pleasure (orother emotional reaction) from normally rewarding stimuli. We will use procedures developed in thecurrent period to manipulate mood state over short time intervals, and we will investigate howtransient negative mood influences activation in brain systems that process emotional and rewardingstimuli.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
2P50MH060451-06
Application #
7167303
Study Section
Special Emphasis Panel (ZMH1-ERB-L (04))
Project Start
2006-07-01
Project End
2011-06-30
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
6
Fiscal Year
2006
Total Cost
$243,444
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Jacobsen, Jacob Pr; Rudder, Meghan L; Roberts, Wendy et al. (2016) SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept. Neuropsychopharmacology 41:2324-34
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129

Showing the most recent 10 out of 250 publications